PCSK9 and chronic obstructive pulmonary disease: We suggest that higher levels of PCSK9 in BALF are to be considered as a risk factor for inflammatory exacerbation in lung diseases including fibrosis and COPD but intracellular PCSK9 may protect against development of lung disease.